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Latterly, perhaps impelled by the Spirit of the Age 
as well as by the accelerating cost of medical in­
no vation, governments have increasingly found in 
evidence­based medicine a necessary instru ment, 
as well as a sensible one. In the UK, the National 
Institute for Health and Clinical Excellence (NICE) 
has required its mental health guideline develop­
ment groups to use a standard, one­size­fits­all 
approach to evidence pertaining to the various 
treatments used for specific common mental disor­
ders. When judged by the narrow criterion of the 
availability of sufficient numbers of high­quality 
double­blind random allocation controlled trials 
and meta­analyses, it may be fair to conclude that 
the evidence base for the most used treatments for 
depression is weak. However, this kind of null ver­
dict does not take us very far, either in knowledge 
or in the development of practice. In any case, the 
restrictive definition of evidence­based medicine 
in the mental health field which underpins this 
judgement has some adverse consequences and 
needs to be heavily qualified. 
First, there is a pervasive fallacy that a statement 
about a ‘strong’ or a ‘weak’ evidence base is a state­
ment about the weakness of the treatment rather 
than about the limitations of the research methods 
used in the evaluation of that treatment. This 
intro duces damaging confounds. They include the 
consequences of equating a weak evidence­base 
with a weak treatment, or a supposedly strong 
one with a strong treatment. Weak research or 
flawed guidelines may acquire a status they do 
not deserve. 
Second, although there always may be excep­
tions, the fundamental difficulties of most people 
with depression do not resolve with brief inter­
ventions of whatever variety. The natural course 
of depression is often prolonged, relapsing or 
recurrent (Surtees & Barkley, 1994). Although 
patients are significantly helped by any well­
informed and responsive professional intervention, 
including really good clinical management, the 
resistant core of any significant psychopathology 
is a fact of life. To provide a quality mental health 
service requires care and support, and specific 
interventions available when needed in long­term 
packages. The randomised controlled trial (RCT) 
research agenda has so far been unable to take this 
fact sufficiently into account.
Third, by and large, the dysfunctions from which 
patients suffer are not confined to those that can be 
called a single diagnosis. Most patients not only 
meet the criteria for several different symptom­
based diagnoses, but have to cope with many 
sub optimal functions of the personality (Westen 
et al, 2004). They complain of doubt of love, of 
past and present difficulties in terms of personal 
achievement and work, as well as of existential 
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and intimate problems of being, identity and so 
on. By being short­term, RCTs and brief treatment 
interventions avoid difficulties of this sort, whereas 
mental health workers should not, and patients 
cannot, do so.
Thus, for these and other reasons it can be 
argued that the NICE emphasis on RCTs as 
the gold standard in the research evaluation of 
psychological therapy outcome is as unfounded as 
its evidence base is weak.
The position seems to be that different theoretical 
approaches, such as the cognitive, the pharma­
cological, the psychiatric, or the psychoanalytic, 
the clinical or the ‘scientistic’, have very different 
ideas about the principles that should underpin 
the methodology of outcome research and of 
evidence­based guidelines. These are serious and 
important disagreements about what counts as 
quality in evidence and fact, and about the place 
of clinical knowledge in the discourse. These 
different positions translate into the way questions 
about efficacy and effectiveness are asked and 
the way in which they are answered. They give 
rise to serious problems of incommensurability: 
when we ask questions about complex issues 
we must of necessity choose one among several 
approaches to frame our questions and to provide 
the concepts and terminologies we think are best 
suited to define, collect, observe and interpret 
what we count as empirical data. Empirical data 
are, in truth, empirical only up to a point. Beyond 
that point they are highly method­dependent. We 
cannot simply examine the facts obtained by one 
method with the concepts belonging to another. 
To cap it all, the factors that determine which of 
the above approaches is dominant involve deep­
seated personal preferences that are hard waxed 
against discrepant findings or arguments.
This article is in three sections. The first outlines 
the preliminaries necessary to provide a frame of 
reference for the review of evidence that follows. 
This evidence base is often an inconclusive and 
contradictory set of findings from treatment out­
come studies relevant to depression. Often it seems 
more like a quagmire than firm ground. I focus 
here on the evidence pertaining to psychoanalytic/
psychodynamic approaches. I hope that it will be 
possible to begin to see how, if we judge by lights 
other than those subscribing to the primacy of 
method, the evidence base for psychodynamic ap­
proaches is not actually that weak. There is, in fact, 
a web of evidence supporting their value. Indeed, 
because this extends into so many domains it has 
not been possible to give more than a hint of the 
wide range of different types of evidence that have 
a bearing on this issue. In the final section I discuss 
this evaluation and suggest some conclusions.
Preliminaries for a frame  
of reference
Prevalence, course and nature  
of depression
In high­income countries, over the course of a 
year about 6% of the adult population will suffer a 
major depressive disorder, and 6% will experience 
dysthymia, with the lifetime prevalence of the 
disorder being about 17% (Weissman et al, 1991). In 
the community, between 20 and 30% of untreated 
depressed individuals will still be depressed a year 
later (Sargeant et al, 1990). Put the other way round, 
70% of people with untreated depression will 
recover without intervention in the course of a year. 
Generally, the risk of further episodes over the 10 
to 15 years after an index episode is more than 85% 
(Mueller et al, 1999). Of those who initially respond 
to medication, 30% will relapse within a year, rising 
to as many as 75% after 5 years (Hirschfeld, 1991). 
Each person with major depressive disorder will 
experience on average four episodes during their 
lifetime. Each of these episodes will last an average 
of 20 weeks with ongoing symptoms and disability 
during the periods of ‘remission’ (Judd, 1997; Judd 
et al, 1997).
As these figures suggest, depression can be a 
circumscribed, self­limiting condition for some 
people, but a significant proportion will suffer a 
pattern of remission and relapse (Surtees & Barkley, 
1994), and will show a tendency for a deteriorating 
outlook as time goes by (Paykel, 1994) (Box 1). Yet, 
the majority of RCTs of psychological therapy and 
pharmacotherapy involve short­term treatments 
of acute­phase depression, with non­existent or 
brief follow­ups. These studies therefore do not 
provide reliable information about efficacy over 
Box 1 The natural course of depression
For about 50% of individuals, the duration of ••
illness is 3 months; thereafter the probability 
of remission diminishes rapidly 
60% of people receiving antidepressant ••
medi cation still meet the criteria for major 
depressive disorder after 1 year of treat­
ment, and 20% after 2 years
Up to 90% of patients develop new episodes ••
after recovery 
Only 20% of people hospitalised for ••
depression remained well over a 15­year 
follow­up
(Lee & Murray, 1988; Coryell et al, 1994; 
Goldberg et al, 1998; Spijker et al, 2002) 
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the medium and longer term, especially in relation 
to those who have more chronic or severe forms of 
depression.
The taxonomy of depression 
The data above were arrived at using diagnostic 
schemes based on the idea that depression, general­
ised anxiety disorder and obsessive–compulsive 
disorder are distinct entities. If they truly were 
separate entities, they would be expected to occur 
independently of each other, to have their own 
particular aetiology, and each would respond to 
its own specific treatment acting on pathological 
processes specific to the disorder. What we find 
does not support this idea (Box 2).
The psychoanalytic/psychodynamic 
model of therapy
The term ‘psychodynamic psychotherapy’ encom­
passes therapeutic approaches derived origin­
ally from psychoanalysis and depth psychology. 
Although psychodynamic psychotherapies are 
various, the role of early development, unconscious 
processes and the transference significance of 
the therapeutic relationship are to some extent 
common to most. 
 In classical psychoanalysis the analyst seeks 
to follow the patient rather than to set or impose 
an agenda. Psychoanalysts try to understand a 
unique process set in motion by the patient’s pre­
occupations, anxieties, difficulties, character and, 
above all, by his or her way of relating. Exploring 
sensitive personal areas requires a stable, sympa­
thetic yet objective discipline. The approach is 
based on a view that everyone is subject to a flux 
of internal conditions, which to some extent are 
always going to be difficult for the individual 
to deal with or fully acknowledge. The psycho­
analyst’s theoretical knowledge and personal 
analysis provides a detailed familiarity with the 
nature of these internal states and the powerful 
feelings associated with primary relationships in 
the child and the adult. 
In psychoanalysis, the patient uses the couch, 
has sessions five times a week, and the treatment 
lasts for some years. Although in some ways it can 
be likened as much to education as to a form of 
treat ment, in significant respects it differs from 
both. Like any significant piece of learning, psycho­
analytic change occurs slowly but the emotional 
and cognitive developments that are involved are 
based on learning by internalisation rather than 
learning by rote, or memorising. This internalisa­
tion process involves the patient in a sustained 
contact with previously under­explored areas of 
their personality as they function within the spe­
cialised relationship between patient and analyst 
(Milton, 2001). Analysts use their knowledge and 
training to be able to see into, to challenge, and to 
contain and to tolerate the areas of difficulty the 
patient brings. As a result, the patient gradually 
takes in a capacity to feel more comfortable with 
these and other emotionally difficult areas.
 Psychoanalysis can be engrossing and fascinating. 
Because of its meaningfulness many patients feel 
much supported, partly because of its openness to 
emotionally demanding or turbulent areas. This 
explains why many people will make considerable 
sacrifices to have an analysis. However, it is not 
to everyone’s taste or liking. Psychoanalysis has 
the capacity to evoke great hatred and contempt as 
well as great appreciation and gratitude.
To make the value of psychoanalytic thinking 
available to patients for whom a full analysis is 
either impossible for practical reasons, or not indi­
cated for clinical ones, many shorter or less inten­
sive forms of individual and group psycho therapy 
have been devised. The general psychoanalytic 
models that underpin these applications remain 
non­directive and are offered in short­, medium­ 
and longer­term formats. Centres of psychotherapy 
Box 2 Problems with single-disorder research 
and treatment guidelines 
Apparently exact rates of diagnosis ••
lend pseudo­objectivity to the familiar 
taxonomy
Results depend on which of several ••
diagnostic schemes is used (Goldberg & 
Goodyer, 2005)
A minority of patients satisfy the criteria ••
of only one diagnosis. Patients meeting 
criteria for major depressive disorder are 
nine times more likely than chance to meet 
the criteria for other conditions (Angst & 
Dobler­Mikola, 1984, 1985)
57.5% of patients with depression also have ••
anxiety disorders (Kessler et al, 2003) 
50–90% of patients with Axis I conditions ••
also meet the criteria for other Axis I or Axis 
II disorders (Westen et al, 2004)
Index presentations commonly change over ••
time, with the features of depression, anxiety, 
phobic or obsessive­compulsive disorders 
now uppermost, now unobtrusive 
Patients complain of problems of functioning ••
and of life not captured by measures of 
symptoms or categorical diagnoses
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in the UK offer a model of once­weekly psycho­
analytic psychotherapy over 1 year (45 sessions), 
or occasionally a little longer. The social insurance 
funded healthcare systems of a number of European 
countries routinely fund up to 300 sessions of 
twice­ or thrice­weekly psychoanalytic psycho­
therapy sessions. 
Over the years a number of more structured, and 
usually short, forms of psychodynamic therapy 
have also been developed. Typically, these include 
actively formulating a focus on the particular 
unconscious operations and emotions thought to 
underlie the patient’s symptoms and complaints. 
The model of Davanloo (1980), for instance, is 
organised around the idea of a triangle of conflict 
(feelings, anxiety and defence) and a triangle 
of person (past, therapist and current) to frame 
interventions. The brief psychotherapy model of 
Malan (1976) is similar. However, although these 
structured approaches are more concerned with 
achieving specific focal aims, patients are still 
offered and still obtain insight. They are not given 
homework or didactically taught mental skills 
such as thought­monitoring and re­framing.
A brief account of the psychoanalytic 
understanding of depression
Psychoanalysis regards mourning and depression 
as types of bio­psychological reactions to loss (Box 
3). Any significant loss stimulates fear, anxiety 
and anger. The activity of the emotional system 
connected with fight or flight is triggered and 
emotional systems to do with nurturance are 
enormously disturbed. These powerful emotional 
reactions have to be managed by the organism. 
Freud (1917) com pared the mental processes 
involved in mourning with those in depression. 
The ability to mourn is an adaptive capacity 
involving relinquishment. It can lead to mental 
growth and the return of the capacity to feel love 
at a new level. Relinquishment is more difficult for 
those susceptible to depression, because of under­
lying difficulties with tolerating the fundamental 
separate ness of the loved object. Such individuals 
are unable to cope with the love and the hate that 
arise in connection with absence while at the same 
time feeling to some degree secure. Their common 
origin in loss means that these two major states of 
mind can coexist and also interact with each other 
in very significant ways.
 Mourning the lost object is one of the ways it is 
possible to recover from depression. This is what 
is happening over the course of the self­limiting 
depressions that so commonly occur at the turning­
points of life. In mourning, individuals remain 
consciously preoccupied with whom or with 
what has been lost, but in deep depression people 
often no longer know why they are depressed. In 
mourning it is the world that is felt to have lost 
meaning but in depression it is the self that is 
viewed as diminished or bad. The self undergoes 
this alteration through its becoming identified with 
the lost object. Identification is an unconscious 
mechanism which involves ‘becoming the same 
as’. In depression, identification occurs on the basis 
of sympathy with the object, sometimes out of guilt 
or sometimes as a way of keeping the relationship 
with the lost person present­within rather than 
absent­without. 
The explanation of these differences between 
mourning and depression rests on the finding 
that the acceptance of the loss is more difficult 
in depression (Klein, 1940). Although we would 
be faithless and shallow if we lacked all tenacity 
in our relations with the world, in those with a 
vulnerability to depression the possibility that 
the tie to the object might be loosened feels not 
possible. There tends to be too much ambivalence 
and insecurity in relation to the love object to allow 
for this. There is a conflict between feelings of love 
and antagonism. Also, a desperate effort to spare 
the loved object from aggression lends intense 
painfulness to the internal struggles of the person 
who is prone to depression. This ‘sparing’ is a sine 
qua non of depression and is its ethical dimension. 
Because aggression cannot simply be wished out of 
Box 3 Some elements of the psychoanalytic 
theory of depression 
Excessive neediness, dependence and am­••
bivalence in love relationships predispose 
to depression after object loss 
Earlier developmental difficulties with ••
object loss are continuously re­evoked in 
the course of later relationships of work and 
love. Just as ‘every finding of an object is a 
re­finding’, every loss revives an earlier one 
(Freud, 1905; Klein, 1940)
Early feeding and affective bond experiences ••
are central to nurturance and fight­or­flight 
systems. They are of particular importance 
in a vulnerability to depressive disorders in 
adulthood
An excessively severe or envious super••  ego 
(Freud, 1917) influences the various levels 
of severity, chronicity and refractoriness 
that depression can take
Both environmental and constitutional ••
(genetic) factors play a part
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existence, the attempt to spare the object inevitably 
means that the hostility must be turned inward. 
This is how people who are depressed come to 
believe that they are bad, disliked, hated or hateful. 
Many of the somatic and vegetative symptoms of 
depression arise from inhibited feelings of arousal, 
hostility and fear operating at the somatic level 
as well as within the more familiar symbolic and 
representational levels of feeling and thought. 
This turning of aggression and anxiety against the 
self is mediated by an internal structure, the critical 
agency, the superego. The superego is coloured by 
the individual’s own hostile and envious feelings 
so that, other things being equal, the more an 
individual controls his or her aggression towards 
others the more severe their superego becomes. 
Although ultimately our dispositions are the 
outcome of gene–environment interactions of 
enormous complexity, the emotional work we are 
able to do with the troubles of our own minds can, 
over the course of time, make a big difference to 
our final outcome.
The outcome evidence for 
psychoanalytic/psychodynamic 
treatments of depression 
The observations summarised in Box 2 support 
the view of many clinicians that the current way 
of classifying and analysing data dismembers 
other wise instructive relationships that exist 
between the different types of symptom found 
in patients with a broader category of ‘common 
mental disorder’. However, the idea of distinct, 
homogeneous mental ‘diseases’ has dominated 
research and guideline development (including 
those of NICE) in the past 25 years, exerting great 
influence on the type of study done and the kind of 
results available. (For a good general review of the 
evidence for psychodynamic therapies see Fonagy 
et al, 2005.) What follows will therefore include the 
results of some meta­analyses and trials that have 
used the concept of common mental disorders as a 
way of describing their study populations. 
Short-term psychodynamic 
psychotherapy
In line with general usage, the various shorter­term 
formats, whether structured or non­directive, will 
be referred to collectively as short­term psycho­
dynamic psychotherapy (STPP). Most of the RCTs 
examining the efficacy of psychoanalytic or psycho­
dynamic approaches have studied forms of STPP. 
Usually this means no more than 20 sessions. 
Efficacy of psychological therapy in the treatment 
of generic disorders
In a mother of all meta­analyses, a meta­analysis 
of 45 meta­analyses of the results of a wide variety 
of brief psychological, educational and behavioural 
treatment trials for an equally wide range of non­
psychotic disorders, Lipsey & Wilson (1993) came 
up with an estimate of the efficacy of psycho logical 
interventions as a ‘generic’ type. They found an effect 
size of +0.76 for all forms of psycho logical therapy 
when compared with waiting­list or minimal­
treatment control conditions. This indicates that 
the post­treatment symptoms of those who receive 
any form of brief psychological therapy will be 
about three­quarters of a standard deviation better 
than that of those who do not. This is a worthwhile 
benefit, but under the limited parameters of brief 
therapy research it has been hard to demonstrate a 
clear magnitude of difference between this size of 
effect and that associated with placebo or ‘treatment 
as usual’ (TAU), especially should the treatment be 
of a good standard. 
The reader will come to see how, in spite of 
numerous efforts to pick it apart, a persistent 
thread of non­specificity runs through the findings 
of psy cho logical therapy research trials. This so­
called ‘equivalence paradox’ refers to how difficult 
it has proved for outcome research to demonstrate 
specific differences, whether according to degree of 
effect, diagnosis or type of psychological therapy. 
For this reason, experienced psychotherapy re­
searchers sum marise the previous decades of 
research in their field with conclusions such as, 
‘the generic efficacy of psychotherapy compared 
to no­treatment has been established for a long 
time … from mildly disturbed persons with 
specific limited symptoms as well as from severely 
impaired patients … study after study, meta­
analysis after meta­analysis, have empirically 
validated psychotherapy as a treat ment’ (Lambert, 
1992: p. 97). Luborsky et al in 1975 applied the term 
‘Dodo bird effect’ to the way every research camp 
in psychological therapy would present data that 
prove that its favourite is the best, while the rival is 
perfidious. The description refers to Lewis Carroll’s 
Alice in Wonderland, in which the Dodo silences the 
bitter squabbles at the end of a race by announcing 
that ‘everybody has won and all must have prizes’. 
The stability of Luborsky et al’s conclusion was 
more recently confirmed by Wampold et al (1997).
Efficacy of generic psychological therapies in the 
treatment of depression
Robinson et al (1990), in their admirably lucid review 
of 58 controlled studies of the use of psychotherapy 
with patients with a formal diagnosis of depression, 
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found effect sizes of 0.73 post­treatment and 
0.68 at follow­up. These are of the same order as 
those quoted above for a much wider group of 
disorders. Their figures indicated that collectively 
these differ ent types of psychological therapy offer 
a moderate benefit in the treatment of depression 
compared with no treatment. Although the 
authors’ initial analysis found the effect sizes for 
cognitive, behavioural and cognitive–behavioural 
therapy (CBT) to be about twice those of ‘general 
verbal therapies’ (a category that included STPP), 
they found that this difference disappeared when 
the treatment allegiance of the researcher and the 
quality of the trial were taken into account. Their 
ultimate finding was that there was ‘no reliable 
difference’ between the efficacies of different forms 
of therapy in the treatment of depression. Each 
form was making roughly equal contributions to 
the final overall effect.
Efficacy of STPP compared with no or minimal 
treatment for diagnosed depression
The Cochrane review by Abbass et al (2006) found 
only two RCTs of sufficient quality giving data on 
the more exact question of the efficacy of STPP v. 
‘no treatment’ or TAU in patients with a formal 
diagnosis of depression. This was out of a total 
of 23 RCTs examining STPP in the treatment of 
common mental disorders. In an earlier review, 
Leichsenring et al (2004) had found a third study. 
The three studies were as follows.
De Jonghe et al (2004) In the treatment of 
adults with mild to moderate major depressive 
disorder (75% having an illness of less than 2 
years’ duration), the authors compared a form of 
STPP (maximum of 16 sessions) alone with STPP 
and antidepressant medication. Although there 
were marked differences in their acceptability to 
patients, the efficacy of both formats in terms of 
effect size, imputed on the basis of the difference 
between baseline measures and measures at 24 
weeks in the two groups, was large (≥ 0.8) and 
more or less equivalent. Note how similar this is to 
the value reported by Lipsey & Wilson (1993). This 
study is considered further below.
Thompson et al (1987) In the treatment of ma­
jor depressive disorder in the elderly the authors 
compared 16–20 sessions of STPP with an equiva­
lent number of CBT and behavioural therapy ses­
sions and a waiting­list control state. By the end 
of 6 weeks, patients in the treatment conditions 
showed improvement of the familiar order, where­
as controls did not. The results of this study also 
have a bearing on the comparative efficacy of the 
different forms of psychotherapy (see below). 
Cooper et al (2003) In the treatment of postnatal 
depression, the authors investigated the efficacy of 
three forms of brief intervention, one of which was 
10 sessions of psychodynamic therapy, compared 
with routine primary care, in post­partum women 
meeting the criteria for major depressive disorder. 
At 4½ months, 70% of the psychodynamic cohort 
were judged to be recovered, compared with 40% 
of the control condition. By the 9­month follow­up, 
however, the benefit of treatment over usual care 
was no longer evident. Moreover, the three forms 
of therapy did not reduce the incidence of further 
episodes of postnatal depression. Psychodynamic 
psychotherapy did, however, seem to accelerate 
recovery, which in the majority of cases would 
have occurred but more slowly. This study had a 
long 5­year follow­up, unlike most RCTs.
Efficacy of STPP compared with no or minimal 
treatment for common mental disorders
According to psychoanalytic theory depression, 
anxiety, obsessional features, personality problems 
and a variety of more subtle manifestations 
are thought to be interconnected in a dynamic 
way. Like an increasing number of psychiatrists, 
psycho analytically informed clinicians and 
researchers have serious reservations about the 
validity of using the single­diagnosis concept of 
depression in outcome trials. Many have argued 
that it makes more sense to study the effects of 
treatment in patient samples that include mixed 
or combined disorders. The search criteria used in 
single­disorder guidelines such as those of NICE 
have tended to exclude the findings of studies of 
this sort. 
Leichsenring et al (2004) This review found 
seven RCTs of sufficient quality which had 
examined STPP against no treatment or TAU for 
a mixture of common mental disorders. Short­
term psychodynamic psychotherapy was found 
to be ‘significantly superior’ to these placebo 
conditions, with effect sizes ranging from 0.59 to 
1.17 depending on the domain measured (target 
problem, general psychiatric symptoms and social 
functioning) and the measure used. ‘No treatment’ 
conditions were found to have ‘before’ and ‘after’ 
effect sizes, which ranged from 0.12 to 0.27, while 
TAU was found to be capable of more substantial 
benefits, ranging from 0.22 to 0.95, depending 
presumably on the intensity, adequacy and quality 
of the TAU provided. 
Abbass et al (2006) This review of 23 RCTs exam­
ined the efficacy of STPP relative to no treat ment or 
TAU in the category of common mental disorder. 
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They pooled patient samples which had originally 
been selected on the basis of several specific com­
mon disorder diagnoses. In addition to depression, 
these included somatoform disorders (irritable 
bowel syndrome, chronic pain, etc.), anxiety and 
personality disorders and the hetero geneous 
mixture of disorders found in a non­responding 
sample of non­psychotic general psychiatric out­
patients. Some of the studies were of samples of 
patients with chronic, difficult­to­treat disorders 
and co morbid substance misuse. Only 8 overlapped 
with Leichsenring’s et al’s review. Combined, the 
23 trials involved 1431 patients. Results indicated 
that STPP (for a mean of 15 sessions) produced 
modest to moderate gains across a wide range of 
symptom categories for a wide variety of patients. 
Furthermore, these gains were often sustained or 
had increased at longer­term follow­up.
Svartberg & Stiles (1991), Crits­Christoph (1992), 
Anderson & Lambert (1995) For mixed disorders, 
these three meta­analyses of all found STPP to be 
superior to no treatment or minimal treatment at 
both short­ and longer­term follow­ups.
Efficacy of STPP compared with no or minimal 
treatment for depressive symptoms in common 
mental disorders
The composite, common mental disorder group 
assembled in the reviews of Leichsenring (2001) 
and Abbass et al (2006) included many patients with 
significant depressive symptomatology across the 
diagnostic categories. Of the 23 studies in Abbass’s 
review, 14 had employed measures of depression. 
In terms of relief from depressive symptoms these 
showed in the short term (≤ 3 months, 11 studies) a 
standardised mean difference (SMD) of 0.59, in the 
medium term (3–9 months, 5 studies) an SMD of 
0.41, and in the longer term (≥ 9 months, 6 studies) 
an SMD of 0.98 relative to controls. These amount 
to moderate treatment effects and, in line with 
trend, the longer­term follow­up finding is more 
substantial.
Efficacy of STPP compared with other forms  
of psychological therapy
The meta­analyses of Crits­Christoph (1992) and 
Anderson & Lambert (1995) similarly found STPP to 
be equal in efficacy to other forms of psychological 
therapy, as did the Leichsenring et al (2004) study. 
Only one meta­analysis, that of Svartberg & Stiles 
(1991) found STPP to be less effective than other 
short­term treatments such as CBT. However, when 
controls for quality were introduced, this putative 
superiority evaporated.
Efficacy of STPP compared with CBT  
and behavioural therapy for depression
Churchill’s et al’s (2001) systematic review of 
controlled trials of brief psychological treatments 
for depression, part of the NHS Health Technology 
Assessment programme, found six studies (five 
randomised controlled and one controlled clinical 
trial) comparing STPP with CBT in formats of less 
than 20 sessions.
Pooling dichotomous recovery/non­recovery 
data suggested that, by the end of the treatment, the 
odds of recovery for patients receiving CBT were 
at least twice those for patients receiving STPP.
 However, the reviewers noted the possibility of 
a bias towards the CBT condition in these trials. 
More than half the studies were conducted by 
researchers with a CBT preference; these trials had 
used psychodynamic therapy only as a secondary 
comparison condition. Again, when ratings for 
the quality of the trial and the quality of treatment 
delivery were included, this marked difference 
disappeared.
 The difference reported between CBT and brief 
psychodynamic treatments also disappeared when 
follow­up data were reported. In two of the studies 
this was at 3 months, and in a third at 1 year. The 
remainder did not report follow­up data.
Leichsenring (2001) came to similar con clusions. 
He confirmed that STPP was associated with statis­
tically significant reductions in depressive 
symptoms before and after treatment. Out of a 
total of 60 possible comparisons between STPP and 
CBT he found no difference in 58, and a small effect 
in favour of CBT in 2. He calculated the mean 
‘before and after’ success rates of STPP and CBT as 
46% and 54% respectively – equivalent to a small 
effect size in favour of CBT. Wampold et al (2002) 
reported similar findings.
Efficacy of psychotherapy compared with 
antidepressants
According to Roth & Fonagy (2004), when psycho­
therapy and medication are offered alone they 
seem to be of roughly equivalent efficacy. Most, 
but not all, of this evidence is from interpersonal 
therapy and CBT studies. The earlier review of 
Robinson et al (1990) found 15 studies examining 
this question, including a few looking at the effect 
of com bining psychological therapy with anti­
depressants. Eight of these 15 studies were of CBT, 
three were of behav ioural therapy and four tested 
what the authors describe as ‘general verbal’ 
therapy, which includes dynamic approaches.
The studies yielded a small effect size in favour of 
psychological therapy, but this may be an artefact. 
Once again, when allegiance effects (Luborsky 
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et al, 1999) were taken into account no reliable 
differences could be found between psycho logical 
therapy and pharmacotherapy. Publication bias 
and selective reporting are now known to have 
influenced findings bearing on this question.
However, there is some evidence (Thase et al, 
1997) that antidepressants are more efficacious for 
people with more severe depression than for those 
with depression of mild to moderate severity, or 
those for whom complex psychosocial factors of 
history and personality are significant parts of the 
presentation.
Efficacy of combined treatments
Augmenting STPP with antidepressants (v. STPP 
alone) De Jonghe et al (2004) examined the issue 
of whether the addition of antidepressants to 16 
sessions of STPP would improve on the outcome 
of major depression of mild to moderate severity 
treated with STPP alone. A sample of about 200 
psychiatric out­patients with major depressive dis­
order was treated and followed up over a 6­month 
period.
Both treatment packages produced broadly 
equivalent positive effects. The success rate in 
the STPP­alone arm was 73% as against 81% in 
the combined treatment arm, with pre–post effect 
sizes on the Hamilton Rating Scale for Depression 
(HRSD) of 1.22 and 1.53 respectively. By 24 weeks, 
HRSD ratings had fallen from an initial average 
of 18 to one of 10. The comparison findings 
indicated a small benefit in favour of combining 
anti depressants with STPP, but these reached 
significance only in respect of the patient’s self­
report measure (with a medium effect size of 0.49). 
Because there was no drug placebo control in the 
trial the mechanism of this effect is uncertain.
Other important findings concerned the strength 
of patients’ attitudes to the two kinds of treatment. 
Although 25 % of psychotherapy patients broke off 
their treatment, psychotherapy still seemed to be 
more acceptable. More patients refused to enter the 
pharmacotherapy arm in the first place, and by 6 
months a further 35% had withdrawn from it. 
Augmenting antidepressants with STPP (v. anti ­
depressants alone) Burnand et al (2002) investi­
gated the question of combined therapy the other 
way around: augmenting antidepressant medica­
tion with a 10­session form of STPP, administered 
in this case by well­trained nurses, to enhance 
the outcomes of patients in an acute­phase major 
depressive episode. The patients had been referred 
to an out­patient psychiatric service, and had 
moderate to severe degrees of depression; half 
had had previous episodes; half had some form 
of personality disorder. They were as a whole 
slightly more ill than the de Jonghe et al (2004) 
sample. The final sample analysed consisted of 74 
patients randomised to the two conditions – anti­
depressants (mainly clomipramine) combined with 
supportive time with a designated key worker v. 
antidepressants plus 10 sessions of STPP with a 
trained nurse­therapist.
After the 10­week treatment period the mean 
HRSD scores in both groups had reduced from 
about 24 to about 9 (P > 0.001) but with little 
difference between the comparison conditions on 
this measure.
However, the combination of STPP and anti­
depressants was better than antidepressants alone 
on several other important indices: patients who 
received STPP were significantly less likely to still 
meet the criteria for major depressive disorder after 
10 weeks (9%) than those who had not (28%).
The combination group needed significantly 
fewer days off work (46 v. 57), and they had both 
a lower rate and fewer days of hospitalisation. 
Cost–benefit comparisons showed that STPP plus 
antidepressants had resulted in savings of $2311 
per patient over the 10­week period. For patients 
in full employment before they became ill savings 
were greater ($3394). 
Once it is recollected that depression can be a 
long­term relapsing condition, the drawbacks of 
the trials summarised above are hard to deny in 
respect of all types of treatment. They are nearly 
all concerned only with the short­term outcome 
of brief treatments. The findings of trials of this 
kind also suggest a ceiling on the effects of brief 
therapies of whatever type. To go beyond these 
limitations it is important to look to studies of 
longer­term treatments of patients with chronic 
or harder­to­treat depression of one kind or 
another. Furthermore, because the dysfunctions 
associated with depression extend beyond what 
symptom measures capture, we need to develop 
our understanding of these and to find ways of 
evaluating change.
Efficacy of treatments of chronic or treatment­
refractory depression
Stimpson et al (2002) found 17 RCTs which exam­
ined various pharmacological approaches to the 
treatment of patients with unipolar depression 
who had not responded to a minimum of 4 weeks 
of antidepressant treatment.
On the basis of these 17 studies, they concluded 
that there was little in the way of evidence to guide 
the treatment of patients who had not responded 
to a first course of antidepressants. Within their 
criteria, they found no satisfactory trials of 
psychological therapy for chronic or treatment­
resistant depression.
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By using more lax inclusion criteria, McPherson 
et al (2005) did find a few studies of psychological 
treatments, including single case studies. These 
mainly used CBT. Although they mostly showed 
reduction in symptoms, they all had short follow­
up times and very small numbers. Interestingly, 
and presumably in response to the severity of the 
psychopathology, the CBT treatments involved 
seemed to be showing a marked tendency to 
become longer than the short 10 or 20 sessions that 
have been a principle selling point of the method. 
In one small study the eight participants had 39 
sessions over 8 months – beginning to approach 
something like a medium­length psychodynamic 
treatment!
Two RCTs are currently under way with this 
patient group. The Tavistock Adult Depression 
Study (Publication ID M0001169680 at http://
www.nihr.ac.uk) is examining the efficacy of 
medium­term (60 sessions) weekly psychoanalytic 
psychotherapy v. TAU in 90 patients with treatment­
resistant depression. Eligibility criteria include at 
least two failed treatments as well as a diagnosis of 
major depressive disorder. The average duration 
of illness is 10–15 years and most patients have 
been found also to meet the criteria for at least one 
DSM Axis II disorder. The trial is due to report in 
2010. A similar multicentre German RCT combined 
with a naturalistic arm began last year. The 
Langzeittherapie bei chronischen Depressionen (LAC) 
study, led by Professor M. Leuzinger­Bohleber, is 
comparing a longer psychoanalytic psychotherapy 
treatment with CBT and has an intended sample 
of 240 (http://www.sfi­frankfurt.de/forschung/
forschungsfeld­2/depressionsstudie.html). 
Efficacy of long­term v. short­term 
psychodynamic/psychoanalytic therapies  
in depression and common mental disorders
The Helsinki Psychotherapy Study Group’s RCT 
(Knekt et al, 2008) has compared the effectiveness 
of two forms of short­term therapy with a long­
term psychodynamic psychotherapy. So far follow­
up data over 3 years have been reported. The study 
also has an arm for full psychoanalysis, which is 
about to report along with further follow­up data. 
The two short­term treatments were a problem­
solving solution (solution­focused therapy) (about 
10 sessions, including family work over 8 months; 
Lambert et al, 1998) and a form of STPP based 
on the Malan model (20 sessions over 6 months). 
The long­term treatment involved 2–3 sessions 
of psychodynamic therapy a week over 3 years 
(average number of sessions was 232). The 326 
participants, between 20 and 45 years of age, had 
been referred and treated as out­patients for mild 
to moderate DSM–IV mood or anxiety disorders 
for at least 1 year; 68% met the criteria for major 
depressive disorder, 44% met those for generalised 
anxiety disorder, 18% met those for personality 
disorder, and 9% had made a suicide attempt.
All three interventions were associated with 
significant reductions on all symptom measures 
(depression, anxiety and general). Over the 3­year 
period the average reduction in Beck Depression 
Inventory (BDI) score was 51% (with effect sizes 
ranging from 0.87 to 1.52). At entry the mean BDI 
score was 18; in those given the two short­term 
treatments this had come down to about 10, and in 
those who had had long­term therapy it was about 
7. These benefits are comparable to those found in 
studies involving CBT. 
Participants who received the short­term treat­
ments typically showed an early response which 
reached an upper limit by 12 months. These gains 
proved lasting over the entire 3­year follow­up.
In contrast, the long­term therapy group 
initially lagged behind, showing significantly less 
improvement over the first year. However, the 
gains in this group gradually increased so that by 
the 3­year point on all measures their symptoms 
were less than those of the short­term treatment 
groups; with respect to anxiety they were four 
times more likely to be recovered, but with respect 
to the depression measures the difference was not 
of the same degree. This pattern has also been 
found in other studies (Kopta et al, 1994).
 Overall, about 20% of those who initially met 
criteria for personality disorder no longer did at 7 
months. In the STPP group there was a continued 
reduction in the features of personality disorder, 
so that by 12 months only 9% met the criteria. This 
continued improvement in personality function­
ing did not occur in the solution­focused therapy 
group.
Evidence from retrospective and prospective 
longitudinal effectiveness studies
Psychological therapies require the patients’ 
personal choice, voluntary mental work and 
engagement. Especially over the medium and longer 
term, RCTs, with their analogies to medication 
trials, do not fit easily with the requirements of 
human relatedness. Practically and ethically it 
is not possible to randomly allocate over long 
durations. It is entirely unrealistic to require RCT 
evidence for the outcome of these longer therapies. 
Instead, the evidence from long­term and, until 
recently, usually retrospective effectiveness studies 
needs to be taken more seriously. 
A carefully designed naturalistic long­term 
follow­up in Germany of 402 patients (of whom 
128 had affective disturbances) who had received 
psych oanalysis and long­term psychoanalytic 
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psychotherapy (Beutel & Rasting, 2002) showed 
that a clinically representative group of patients 
with significant depressive symptoms had moved 
into the normal range of scores. At long­term 
follow­up, this group was doing better in terms of 
days off work than the population norm. The study 
included in­depth qualitative interviews that made 
it possible to discern distinct and differing pat­
terns of change in the way that various personality 
types managed their thoughts and feelings. These 
patterns included the emergence of reflective 
functioning. 
Other studies have confirmed the clinical 
impression that improvement may continue after 
psycho dynamic or psychoanalytic psychotherapy 
ends. The Stockholm Outcome of Psychoanalysis 
Project, for example, has demonstrated that patients 
gained in strength and capacity after treatment had 
ended (Sandell et al, 2000; Blomberg et al, 2001). 
Discussion and conclusions
Do short-term treatments cure 
depression?
Robinson et al (1990) enquired whether the clinical 
effects of short­term psychological and pharmaco­
logical treatments amount to a cure of depression. In 
their sample of studies the mean pre­treatment BDI 
score was 21.8 and post­treatment this had fallen 
to 11.8. The corresponding figures for untreated 
controls were 20.7 and 18.1. The mean BDI score 
of unselected samples from the general population 
is 7.0. For the fraction of the general population 
that is contented this comes down to 4.9. Thus, 
these treatment effects move patients to within 
1 standard deviation of the general population 
mean, and to within 1.5 standard deviations of the 
contented among us. These are not trivial effects 
but even by the restricted sensitivity of the BDI 
they suggest that on a good day the average well­
treated recipient of short­term treatments is still 
more depressed than most of us on a bad day, 
and is even further from the ideal of normative 
functioning. The consistency of these estimates 
points towards there being a ceiling to what can be 
achieved with short­term treatments.
Does the evidence base need to remain an 
industry of small differences?
It is still possible to sum up the current state of 
evidence with the following blanket conclusion: 
antidepressant medication and the different 
varieties of short­term psychological therapy are 
capable of generating an improvement of about 
12–13 points on the BDI, and there is not much to 
choose between them. Also, as clearly indicated 
by the findings of the Robins & Regier (1991) 
study, the ‘placebo’ effect in trials of treatments for 
depression can be consistently large, amounting to 
an average of 10 points’ improvement. 
Viewed in this way, it is understandable that 
many clinicians throw up their hands at a research 
base that seems more like a heap of dust. It does 
seem that in respect of treatment research into 
depression (and other common mental disorders) 
the Dodo bird’s judgement, at least, is alive and well. 
It lives on in an evolutionary backwater maintained 
by three factors: the conviction that short­term 
RCTs are guardians of truth, the continued use 
of instruments that are insensitive to the many 
aspects of patients’ dysfunctionality that lie outside 
symptom frames of reference, and a homoeopathic 
fantasy that brief psychological treatments are 
highly potent. If these items stay as they are, the 
difficulty of demonstrating informative differences 
between therapies will continue until the wishful 
side has overwhelmed realism, probably through 
sheer weight of numbers. 
Within the remit of this article it has only been 
possible to present the evidence from outcome 
trials, and that in a summarised, incomplete way. 
However, when we questioned the inclusion and 
exclusion criteria of guidelines, and the effect of 
continuing to use specific psychiatric diagnoses 
as an organising principle, we found that relevant 
evidence had got left out. Moreover, when we 
allow clinical experience a little more authority 
over short­term outcome research trials, other 
points come into view. If we proceed to admit 
evidence from other kinds of science, a yet 
more interesting range of conclusions becomes 
possible. Epidemiology, observations of natural 
course, developmental psychopathology, studies 
of psychosocial factors, life­events, experimental 
studies and psychoanalytic findings themselves 
know a great deal about the nature and origins of 
depression and, in passing, provide supporting 
evidence for psychoanalytic theories about 
depression. 
Although this more sophisticated conception of 
the evidence base cannot tell us directly which 
treatments will prove effective, it does enable us to 
know the parameters of the disorder and the limits 
on the plasticity of individuals. These are essen tial 
guides to the potential of different treatment. They 
are scales against which to measure some of the 
wilder claims. Psychiatry could go fur ther and re­
introduce other ideas, such as ‘pro found’ v. ‘banal’, 
to counter the narrowness of the sometimes 
pseudostatistical significance/non­significance 
formula. 
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Conclusions 
This wider view of evidence is consistent with the 
following. 
•	 Effect	 sizes	 for	 STPP	 similar	 to	 those	 for	
other therapies and, like them, superior to 
minimal treatment control conditions. The 
NICE depression guideline’s solitary recom­
mendation for psychodynamic approaches 
is ‘Psychodynamic psychotherapy may be 
considered for the treatment of the complex 
comorbidities that may be present along with 
depression’ (National Collaborating Centre 
for Mental Health, 2004: p. 63). In the light 
of the wider evidence available this seems 
nugatory, especially when it is recollected 
that comorbidity is more the rule than the 
exception. The guideline is under revision. 
•	 A	tendency	for	the	effect	of	CBT	to	come	into	
play more quickly than that of STPP, but with 
longer follow­ups the differential effect that 
arises from this delay disappears (Shapiro et 
al, 1994).
•	 Longer-term	 psychodynamic	 and	 psycho-
analytic therapies, by addressing the dys­
functions of persons, may have the potential 
to go above an efficacy ceiling that operates in 
short­term treatments. There are indications 
that patients in longer­term psychoanalytic 
treatments begin to manifest qualitatively 
different types of change, which can move 
them further into the normal range.
•	 Although	 results	 from	 studies	 of	 combined	
drug and psychological therapy may be 
mixed, there is evidence of ‘extra value’ 
from adding STPP to medication. Also, 
adding medication to STPP, especially where 
vegetative symptoms are pronounced, seems 
entirely sensible. There seem to be no trials 
addressing benefits from sequences of CBT 
→ STPP or STPP → CBT.
•	 The	reasons	patients	have	for	preferring	one	
treatment over another, including one form 
of psychological therapy rather than another, 
have been under­explored.
•	 The	 value	 of	 qualitative	 in-depth	 studies	
of single or small numbers of cases and of 
more naturalistic designs has been under­
estimated. 
•	 We	should	think	a	lot	more	about	the	placebo	
effect and the disputes over valuable but 
limited gains. The psychological mechanisms 
involved in the placebo response in depression 
have a role in normal emotional life. The 
belief in good medicines dispensed by good 
people who can provide succour is one of 
the features of normal mental functioning 
that fails in depression. The restoration of 
this belief­function may be important for 
recovery in depression.
All of these considerations are pointers towards 
optimal or enhanced services for patients suffering 
from the complex range of disorders that goes 
under the general rubric of depression. 
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Psychotherapies for depression
MCQ answers
1  2  3  4 
a F a F a F a F
b F b F b F b F
c F c F c F c T
d F d T d T d F
e T e F e F e F
MCQs
In individuals presenting with major depressive 1 
disorder:
there is little likelihood of panic disordera 
full recovery is usual and recurrence unlikelyb 
aside from the symptoms of depression the personality c 
is usually normal
personal loss plays no partd 
there may be ongoing difficulties in personal e 
functioning in periods of recovery.
According to the psychoanalytic theory of 2 
depression:
thoughts and feelings outside core awareness play no a 
part in the condition 
difficulties with anger and aggression are not foundb 
the concept of the ‘object’ refers to any inanimate c 
thing
emotional ambivalence deriving from early childhood d 
relationships and losses is crucial
the depressed person’s superego is usually benign e 
and forgiving.
With respect to the treatment of depression the 3 
evidence indicates that:
short­term psychodynamic psychotherapy offers no a 
benefit
patient preference should not be taken into accountb 
on average, c ≤ 20 sessions of psychological therapy 
will move patients’ Beck Depression Inventory scores 
into the normal range
longer­term therapies (e.g. 300 sessions) may offer d 
benefits not possible with brief treatments
the effects of short­term psychodynamic psycho­e 
therapy are usually evident immediately.
The evidence base with respect to the treatment of 4 
depression: 
offers clear indications about the best treatment of a 
chronic or recurrent depression
is derived from many good­quality RCTs with b 
clinically representative samples and long follow­
ups
is bedevilled by the effects of researcher allegiance c 
and publication bias
is of no valued 
is very reassuring.e 
